跳至主要内容
临床试验/SLCTR/2024/016
SLCTR/2024/016尚未招募1 期

The effect of vitamin D supplementation on quality of life in stage II-III colorectal cancer patients undergoing adjuvant chemotherapy at Hasan Sadikin Hospital: A single-blind, randomized control trials

Andy0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Male and female patients diagnosed with colorectal cancer based on the WHO histopathological classification system.
  • 2. All stage II-III colorectal cancer patients undergoing adjuvant chemotherapy at Hasan Sadikin Hospital from May 2024 to April 2025.
  • 3. Patients above 18 years of age.

排除标准

  • 1. The patient has consumed vitamin D supplements in the last three months.
  • 2. Allergy to vitamin D supplements.
  • 3. The patient has a primary cancer other than colorectal cancer.
  • 4. Patients with short bowel syndrome or patients undergoing gastric bypass surgery.
  • 5. The patient regularly consumes phenobarbital, carbamazepine, dexamethasone, nifedipine, spironolactone, clotrimazole and rifampicin groups.
  • 6. Patient with symptoms of genitourinary stones in the past year.
  • 7. Patient is consuming a thiazide diuretic.
  • 8. Patient with chronic non-infectious disease (liver failure and kidney failure, history of stroke, type I and II diabetes mellitus).
  • 9. Patients with chronic infectious disease (infection lasts >6 months), such as HIV infection, tuberculosis, hepatitis C, HPV, et cetera.
  • 10. Patients who are pregnant, breastfeeding or using oral contraceptives.

研究者

发起方
Andy

相似试验